Michael J. Doherty, Head of Product Development at Foundation Medicine, Inc. (FMI), sold 16,380 shares at $74.87 ($1.2M) on 2018-04-02, disclosed to the SEC on 2018-04-03.
Open-market sale of $1.2M FMI by Head of Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.87 | 8,190 | $613K | 50.0% |
| 2 | $74.87 | 8,190 | $613K | 50.0% |
| Total | $74.87 avg | 16,380 | $1.2M | 100% |
| Filing → |